Bruce Morimoto PhD
Bruce has more than 20 years of experience in both biotechnology and clinical research companies, leading project teams in the development of innovative medicines, as well as providing strategic guidance, designing preclinical and clinical development programs, and advancing the development of new therapies.
Bruce joined Alkahest from Celerion, where he served as Vice President, Scientific Affairs, having previously served as Vice President, Drug Development at Allon Therapeutics. Dr. Morimoto started his career on the faculty of the Chemistry Department at Purdue University where his independent research focused on neuronal signal transduction. Bruce earned his doctorate in biochemistry from UCLA and completed a postdoctoral fellowship at the University of California Berkeley.